Reaction
Distractibility reporting signals
As of the last recalculation, Distractibility appears in 1,138 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is GUANFACINE (PRR 40.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Guanfacine | 17 | 40.1 | 40.2 |
| Atomoxetine Hydrochloride | 35 | 27.7 | 27.8 |
| Methylphenidate Hydrochloride | 67 | 21.9 | 21.9 |
| Asenapine Maleate | 10 | 21.3 | 21.3 |
| Lisdexamfetamine Dimesylate | 36 | 20.6 | 20.6 |
| Methylphenidate | 27 | 17.4 | 17.5 |
| Lithium Carbonate | 13 | 14.1 | 14.2 |
| Haloperidol | 16 | 12.2 | 12.2 |
| Haloperidol Lactate | 16 | 12.0 | 12.0 |
| Vortioxetine | 11 | 11.9 | 11.9 |
| Valproic Acid | 20 | 11.8 | 11.8 |
| Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate | 23 | 10.3 | 10.3 |
| Amphetamine | 4 | 8.9 | 8.9 |
| Rasagiline Mesylate | 5 | 8.2 | 8.3 |
| Cariprazine | 4 | 7.9 | 7.9 |
| Levodopa | 5 | 7.6 | 7.6 |
| Lurasidone Hydrochloride | 8 | 7.0 | 7.0 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 5.9 | 5.9 |
| Brexpiprazole | 5 | 5.5 | 5.5 |
| Cannabidiol | 6 | 4.7 | 4.7 |
| Esketamine Hydrochloride | 4 | 4.1 | 4.1 |
| Pimavanserin Tartrate | 9 | 3.0 | 3.0 |
| Galcanezumab-Gnlm | 5 | 2.9 | 2.9 |